Mendes Renata de S, Pelosi Paolo, Schultz Marcus J, Rocco Patricia R M, Silva Pedro L
Laboratory of Pulmonary Investigation, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Centro de Ciências da Saúde, Avenida Carlos Chagas Filho, s/n, Bloco G-014, Ilha do Fundão, Rio de Janeiro, RJ, 21941-902, Brazil.
Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.
Intensive Care Med Exp. 2020 Dec 18;8(Suppl 1):32. doi: 10.1186/s40635-020-00319-x.
In acute respiratory distress syndrome (ARDS), increased pulmonary vascular permeability makes the lung vulnerable to edema. The use of conservative as compared to liberal fluid strategies may increase the number of ventilator-free days and survival, as well as reduce organ dysfunction. Monitoring the effects of fluid administration is of the utmost importance; dynamic indexes, such as stroke volume and pulse pressure variations, outperform static ones, such as the central venous pressure. The passive leg raise and end-expiratory occlusion tests are recommended for guiding fluid management decisions. The type of intravenous fluids should also be taken into consideration: crystalloids, colloids, and human albumin have all been used for fluid resuscitation. Recent studies have also shown differences in outcome between balanced and non-balanced intravenous solutions. In preclinical studies, infusion of albumin promotes maintenance of the glycocalyx layer, reduces inflammation, and improves alveolar-capillary membrane permeability. Fluids in ARDS must be administered cautiously, considering hemodynamic and perfusion status, oncotic and hydrostatic pressures, ARDS severity, fluid type, volume and infusion rate, and cardiac and renal function. Of note, no guideline to date has recommended a specific fluid composition for use in ARDS; most physicians currently follow recommendations for sepsis.
在急性呼吸窘迫综合征(ARDS)中,肺血管通透性增加使肺易于发生水肿。与宽松的液体管理策略相比,采用保守的液体管理策略可能会增加无呼吸机天数和生存率,并减少器官功能障碍。监测液体输注的效果至关重要;动态指标,如每搏量和脉压变异,优于静态指标,如中心静脉压。推荐采用被动抬腿试验和呼气末阻断试验来指导液体管理决策。还应考虑静脉输液的类型:晶体液、胶体液和人白蛋白均已用于液体复苏。最近的研究也显示了平衡和非平衡静脉溶液在治疗结果上的差异。在临床前研究中,输注白蛋白可促进糖萼层的维持,减轻炎症,并改善肺泡-毛细血管膜通透性。在ARDS中输注液体时,必须谨慎考虑血流动力学和灌注状态、胶体渗透压和流体静压、ARDS严重程度、液体类型、容量和输注速率以及心肾功能。值得注意的是,迄今为止尚无指南推荐用于ARDS的特定液体成分;目前大多数医生遵循脓毒症的相关建议。